You searched for "service"

1614 results found

Audiovisual antics – now you see it, now you don’t

This series of stories is dedicated to those of you with whom some of these moments were shared (or endured) and, above all, to my amazing and long-suffering husband, David Howard. Most of you know him as an exceptional head...

Audiology in this issue...Amplification 2019

Gareth Smith, MSc, AuD, Consultant Clinical Scientist (Audiology), Southend University Hospital, UK. E: Gareth.Smith@southend.nhs.uk In previous areas of the Audiology Features Section, this theme would have been called ‘Hearing Aids’. With the increased interest in ‘over-the-counter’ or ‘direct-to-consumer’ devices, we...

Programming Cochlear Implants - Second Edition

Wolfe and Schafer open their second edition with up-to-date images of brand-specific devices and show various configurations and customisations available to the recipient. For the audiologist, they introduce highly relevant topics such as polar plots for microphones, array types and...

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

FDA Approved Lenire Expands Number of US Clinics

Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

New RSM presidents preview the year ahead

Professor Patrick Axon, President of the UK’s Royal Society of Medicine Otology Section and Michelle Wyatt, incoming President of the section of Laryngology and Rhinology, look forward to the year ahead.

SpeechEasy® for stuttering

In this article, the authors describe their experiences with an altered auditory feedback (AAF) device: SpeechEasy® during a random clinical trial. AAF has been reported in other laboratory studies to reduce stuttering events without influencing the rate, intensity or frequency...

Open hearing-aid fittings or closed

There is always a balance between different types of hearing aids and their advantages and disadvantages that influence choice of device and ultimately user preference. Personal choice also plays a role when deciding on behind the ear or in ear...

Early vs late activation of cochlear implant device

Device activation after cochlear implant surgery was typically performed after wound healing, and varies anytime from three to four weeks after surgery. Nowadays, activation is performed as early as two to three days after surgery. The authors evaluated the effect...

Sustainability guidelines to reduce single-use items in ENT outpatients

ENT surgery generates significant waste, with single-use instruments and packaging as key contributors. This article outlines recommendations on sustainable practice that can be adopted into ENT departments. Climate change is one of the greatest threats to human health in the...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Developments in diagnostic approaches for acutely dizzy patients

The acutely dizzy patient can be a diagnostic and management dilemma for emergency departments and general practitioners, with many patients consequently having delayed access to specialised assessment and treatment. David Jay tells us about HINTS, a bedside test that can...